Louise Rodino-Klapac - Insider Trading & Ownership

Entity
Individual
Location
215 First Street, Ste 415, Cambridge, MA
Summary
The estimated net worth of Louise Rodino-Klapac is at least $11.9M dollars as of June 25, 2024. Louise Rodino-Klapac is the Head of R&D, CSO of Sarepta Therapeutics, Inc. and owns shares of Sarepta Therapeutics, Inc. (SRPT) stock worth about $11.9M.
All Insider Reports
All Insider Reports

Ownership of Louise Rodino-Klapac

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SRPT Sarepta Therapeutics, Inc. Head of R&D, CSO $11.9M Jun 21, 2024

Insider Transactions Reported by Louise Rodino-Klapac:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.